The U.S. Food and Drug Administration says it has approved new labeling for another opioid designed to limit painkiller abuse.

The FDA said Friday that Pfizer Inc.’s Embeda can have labeling indicating that it has properties expected to reduce abuse of the drug when it is crushed and taken orally or snorted.